The cell usually converts to a more specific kind (Figure 2)
IV therapy is generally considered safe for appropriate candidates when administered by licensed clinicians under physician supervised protocols
Angiogenesis and Vascular Repair BPC-157 has been shown to promote angiogenesis the formation of new blood vessels in multiple experimental models
02 Prepare your supplies Lay out one BAC water vial, one syringe for reconstitution, one syringe for the dose, and at least two alcohol swabs
If you are coming into the office, one of our providers will administer the injection subcutaneously or intramuscularly, depending on your treatment plan
Commonly Reported Research Observations Injection-site redness or irritation Temporary swelling or warmth sensation at the administration site Burning or stinging during administration Temporary skin sensitivity or irritation Mild headaches Temporary fatigue or tiredness Mild nausea Temporary itching or flushing sensations Temporary blue-tinted discoloration beneath the administration area in some research settings Copper-Related Research Considerations Because GHK-Cu is a copper-binding peptide, some research protocols may monitor for: Copper- and zinc-balance variability Increased sensitivity in higher-frequency protocols Temporary skin-related response variability Individual differences in antioxidant-response pathways Research involving prolonged or higher-frequency protocols commonly investigates the inclusion of: Zinc supplementation Vitamin C supplementation alongside GHK-Curelated research models
